Thrivent Financial for Lutherans’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,049
Closed -$210K 2460
2023
Q1
$210K Hold
1,049
﹤0.01% 2376
2022
Q4
$249K Buy
+1,049
New +$249K ﹤0.01% 2298